How Precision Medicine Is Shaping the Future of the Everolimus Market
The Everolimus Market is changing alongside broader trends in precision medicine, targeted oncology, and advanced transplant management. Everolimus acts on the mTOR pathway and is prescribed for selected conditions where its use is clinically appropriate. The market is expected to increase from US$ 1.62 billion in 2025 to US$ 2.64 billion by 2034, reflecting a CAGR of 5.58% during...
0 Commentarii 0 Distribuiri 15 Views 0 previzualizare